Track Your CD4 Count and Viral Load! Use TheBody.com's New Health Tracker!

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Zerit (Stavudine, d4T)

The Basics | News | Research

See also: Drug Interactions | Medication Side Effects

Show Archived (Historical) Articles

Brand Name:	Zerit
Generic Name:	Stavudine, d4T
Adult Single Dose:	Patients weighing at least 133 lbs (60 kg): one 40-mg capsule (every 12 hours) Patients weighing less than 133 lbs (60 kg): one 30-mg capsule (every 12 hours)
Food & Liquid Restrictions:	None
Drug Class:	NRTI

The Basics

An Overview of Zerit (Stavudine, d4T) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
Zerit (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Stavudine (Zerit) (January 27, 2009)
To read PDF, click here
From AIDS InfoNet
Patient Information About Zerit (Stavudine, d4T) (PDF) (November 2008)
From Bristol-Myers Squibb Company
Zerit (Stavudine, d4T) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
d4T (Stavudine, Zerit) (October 26, 2006)
From AIDS Treatment Data Network

News

FDA Approval of Three Generic Stavudine Formulations (December 30, 2008)
From U.S. Food and Drug Administration
Drop d4T From First-Line Therapy, WHO Advises Low-Income Countries – If You Can Afford To (August 8, 2006)
In aidsmap.com

Research

d4T Toxicity Risk 7-Fold Higher When Started With TB Treatment (June 18, 2009)
From aidsmap.com
HIV JournalView: Study Ties Insulin Resistance to NRTIs, Not PIs (September 2005)
d4T and 3TC are associated with insulin resistance and high insulin levels; indinavir is associated only with elevated insulin levels; and no link to insulin abnormalities is found for AZT or ddI.
From The Body PRO
Predicting Lipoatrophy After Treatment Initiation (February 9, 2004)
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.